BioCentury This Week
Claim This Podcastby BioCentury
Podcast Authority
Beta
Podcast Overview
<p>BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.<br><br>For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.</p>
Language
🇺🇲
Publishing Since
4/22/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for BioCentury This Week
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 27, 2026
Ep. 368 - ASCO Preview, China Policy, ADC Linkers
BioCentury analysts discuss pancreatic cancer innovation, ADCs, and diagnostics at ASCO, offering insights into Revolution's daraxonrasib and other key readouts.
May 19, 2026
Ep. 367 - FDA, obesity targets and the rise of DACs
Steve Usdin interviews Marty Makary about recent FDA leadership changes and their impact on obesity drug targets and decision-making.
May 12, 2026
Ep. 366 - Europe's need for speed: Bio€quity takeaways
BioCentury's analysts interview Detlev Mennerich and Mehdi Ainouche about Europe's regulatory race and Bio€quity takeaways.
378 total episodes available with 35 transcripts
Recent guests on BioCentury This Week
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Detlev Mennerich
Guest
Mehdi Ainouche
Guest
James Kyle Bryan
Guest
Christoph Broja
Guest
Ya-Ting Lei
Guest
Luther (Ruizhe) Zhao
Guest
Similar Podcasts
Discover related shows you might enjoy
The Readout Loud
STAT
Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
The BioCentury Show
BioCentury
Business Of Biotech
Ben Comer
Biotech 2050 Podcast
Biotech 2050
The Long Run with Luke Timmerman
Timmerman Report
The Top Line
Fierce Life Sciences
Big Technology Podcast
Alex Kantrowitz
Nature Podcast
Springer Nature Limited
Odd Lots
Bloomberg
Masters of Scale
WaitWhat
Capitalisn't
University of Chicago Podcast Network
Economist Podcasts
The Economist
a16z Podcast
Andreessen Horowitz
WSJ Tech News Briefing
The Wall Street Journal
Deep-dive analytics for BioCentury This Week
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is BioCentury This Week?
<p>BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.<br><br>For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.